Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies
Cancer Treatment Reviews · 2025-09 · 139 · 102980
DOI: 10.1016/j.ctrv.2025.102980 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2025-09. Verfasst von Federica Giugliano und 12 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U981, Gustave Roussy, Villejuif, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Oncology and Hematol…. Hauptthemen laut MEDLINE: Breast Neoplasms, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Society for Medical Oncology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM U981, Gustave Roussy, Villejuif, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Oncology and Hematology-Oncology, University of Milano, Milan, Italy.
- Clinical and Translational Oncology, Scuola Superiore Meridionale Via Mezzocannone, 4 80134 Naples, Italy.
- Department of Medical Oncology, Gustave Roussy, Villejuif, France; INSERM U1279, Gustave Roussy, Villejuif, France.
- Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
- Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
- Translational Research Unit, Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy.
Förderung
- European Society for Medical Oncology
Zitieren
APA
Giugliano, F., De Angelis, C., Pistilli, B., Viale, G., Bianchini, G., Giuliano, M., Malorni, L., Taurelli Salimbeni, B., Esposito, A., Giordano, A., Yap, T. A., Curigliano, G., & Criscitiello, C. (2025). Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies. Cancer Treatment Reviews, 139, 102980. https://doi.org/10.1016/j.ctrv.2025.102980
Vancouver
Giugliano F, De Angelis C, Pistilli B, Viale G, Bianchini G, Giuliano M, et al. Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies. Cancer Treatment Reviews. 2025;139:102980. doi:10.1016/j.ctrv.2025.102980
BibTeX
@article{Giugliano2025,
author = {Giugliano, Federica and De Angelis, Carmine and Pistilli, Barbara and Viale, Giulia and Bianchini, Giampaolo and Giuliano, Mario and Malorni, Luca and Taurelli Salimbeni, Beatrice and Esposito, Angela and Giordano, Antonio and Yap, Timothy A and Curigliano, Giuseppe and Criscitiello, Carmen},
title = {Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies},
journal = {Cancer Treatment Reviews},
year = {2025},
volume = {139},
pages = {102980},
doi = {10.1016/j.ctrv.2025.102980}
}
EUVIMED